These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 6771949)
1. Thrombocytopenia in Graves' disease: effect of T3 on platelet kinetics. Kurata Y; Nishioeda Y; Tsubakio T; Kitani T Acta Haematol; 1980; 63(4):185-90. PubMed ID: 6771949 [TBL] [Abstract][Full Text] [Related]
2. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis. Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274 [TBL] [Abstract][Full Text] [Related]
3. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content. Larsen PR J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364 [TBL] [Abstract][Full Text] [Related]
4. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease. Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159 [TBL] [Abstract][Full Text] [Related]
5. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease. Chen JJ; Ladenson PW J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547 [TBL] [Abstract][Full Text] [Related]
6. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism. Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562 [TBL] [Abstract][Full Text] [Related]
7. Depressed reticuloendothelial clearance of platelets in rats after trauma. Kaplan JE; Moon DG; Minnear FL; Saba TM Am J Physiol; 1984 Feb; 246(2 Pt 2):H180-8. PubMed ID: 6696130 [TBL] [Abstract][Full Text] [Related]
8. Transient recurrence of hyperthyroidism after delivery in Graves' disease. Amino N; Miyai K; Yamamoto T; Kuro R; Tanaka F J Clin Endocrinol Metab; 1977 Jan; 44(1):130-6. PubMed ID: 576228 [TBL] [Abstract][Full Text] [Related]
9. Persistently increased gastrin and decreased pepsinogen concentrations in serum from some patients with Graves' disease of triiodothyronine-predominant type and common type. Fukao A; Takamatsu J; Shimamoto C; Kuma K; Ohsawa N Thyroid; 1998 Mar; 8(3):259-63. PubMed ID: 9545113 [TBL] [Abstract][Full Text] [Related]
10. Value of simultaneous T3, T4, and TSH measurements for management of graves' disease in children. Golden MP; Kaplan SA; Lippe BM; Lee WN Pediatrics; 1977 May; 59(5):762-7. PubMed ID: 577011 [TBL] [Abstract][Full Text] [Related]
11. Lymphocyte-platelet crosstalk in Graves' disease. Kuznik BI; Vitkovsky YA; Gvozdeva OV; Solpov AV; Magen E Am J Med Sci; 2014 Mar; 347(3):206-10. PubMed ID: 23571468 [TBL] [Abstract][Full Text] [Related]
13. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients. Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435 [TBL] [Abstract][Full Text] [Related]
14. [Serum thyroid hormones and TSH response to TRH during treatment of Graves' disease by carbimazole (author's transl)]. Lorcy Y; Heim J; Auvray E; Allannic H Ann Endocrinol (Paris); 1979; 40(4):441-2. PubMed ID: 117739 [TBL] [Abstract][Full Text] [Related]
15. Erythrocyte carbonic anhydrase-I concentrations in patients with Graves' disease and subacute thyroiditis reflect integrated thyroid hormone levels over the previous few months. Kiso Y; Yoshida K; Kaise K; Kaise N; Fukazawa H; Mori K; Abe K; Yoshinaga K J Clin Endocrinol Metab; 1991 Feb; 72(2):515-8. PubMed ID: 1899425 [TBL] [Abstract][Full Text] [Related]
16. Modulation of mild bleeding disorder during remissions and exacerbations of Graves' disease. Zeigler ZR; Iannuzzi D South Med J; 1989 Nov; 82(11):1416-8. PubMed ID: 2814628 [TBL] [Abstract][Full Text] [Related]
17. [Initial 111In-platelet kinetics: indicator of platelet sequestration/destruction site or quality control of platelet labelling?]. Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Starcević V; Bosnjaković V Glas Srp Akad Nauka Med; 2005; (48):101-18. PubMed ID: 16405234 [TBL] [Abstract][Full Text] [Related]
18. Platelets in hyperthyroidism: studies on platelet counts, mean platelet volume, 111-indium-labeled platelet kinetics, and platelet-associated immunoglobulins G and M. Panzer S; Haubenstock A; Minar E J Clin Endocrinol Metab; 1990 Feb; 70(2):491-6. PubMed ID: 2298861 [TBL] [Abstract][Full Text] [Related]
19. Epithelial hyperplasia and decreased colloid content of the thyroid gland in triiodothyronine-predominant Graves' disease. Takamatsu J; Takeda K; Katayama S; Sakane S; Morita S; Kuma K; Ohsawa N J Clin Endocrinol Metab; 1992 Oct; 75(4):1145-50. PubMed ID: 1400885 [TBL] [Abstract][Full Text] [Related]
20. Platelet removal from the circulation by the liver and spleen. Kaplan JE; Saba TM Am J Physiol; 1978 Sep; 235(3):H314-20. PubMed ID: 696842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]